Substituted diketopiperazines as oxytocin antagonists
US7514437B2 · kind B2 · utility
8Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2002 |
| Grant date | Apr 7, 2009 |
| Priority date | — |
| Expiry date | Dec 30, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a mammal in need thereof of an effective amount of a compound of the formula (I)and/or a physiologically acceptable derivative thereof, wherein the substituents have the meaning given in the description. Disclosed are also novel compounds of formula (I) and processes for their preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.